IDEXX Laboratories (IDXX) Q3 Earnings Leave Its Premium Valuation In Focus
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- IDXX Idexx Laboratories
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that IDEXX Laboratories belongs to, so it often moves with news about it.
- LNTH Lantheus Holdings
Lantheus Holdings is a peer of IDEXX Laboratories in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- NEOG Neogen
Neogen is a peer of IDEXX Laboratories in in vitro and in vivo diagnostic substances; rivals often move on the same news.
- LLY Eli Lilly and
Eli Lilly and is a large health company like IDEXX Laboratories; big names in a sector often move together.
- JNJ Johnson & Johnson
Johnson & Johnson is a large health company like IDEXX Laboratories; big names in a sector often move together.
- ABBV AbbVie
AbbVie is a large health company like IDEXX Laboratories; big names in a sector often move together.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| IDXX | -16.23% | -17.96% | base | +4.10% | -0.16% | +0.60% | +5.21% |
| XLV | -2.31% | +0.48% | base | +3.08% | +0.65% | +0.47% | +2.39% |
| LNTH | -0.68% | -0.30% | base | +0.35% | -0.08% | -0.18% | +0.21% |
| NEOG | +0.08% | -2.48% | base | +2.81% | -3.55% | -2.85% | -0.29% |
| LLY | -8.42% | +0.54% | base | +0.62% | -2.48% | -3.88% | +0.21% |
| JNJ | +1.93% | +2.66% | base | +3.82% | +2.34% | +3.82% | +5.99% |
| ABBV | +0.13% | +3.12% | base | +2.66% | +1.15% | +1.97% | +2.59% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
IDEXX Laboratories (IDXX) Q3 Earnings Leave Its Premium Valuation In Focus Yahoo Finance
Source: Yahoo Finance
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | that day | +2.66% | final price |
| ABBV | the next day | +1.15% | final price |
| ABBV | two days later | +1.97% | final price |
| ABBV | three days later | +2.59% | final price |
| ABBV | three days earlier | +3.12% | final price |
| ABBV | five days earlier | +0.13% | final price |
| IDXX | that day | +4.10% | final price |
| IDXX | the next day | -0.16% | final price |
| IDXX | two days later | +0.60% | final price |
| IDXX | three days later | +5.21% | final price |
| IDXX | three days earlier | -17.96% | final price |
| IDXX | five days earlier | -16.23% | final price |
| JNJ | that day | +3.82% | final price |
| JNJ | the next day | +2.34% | final price |
| JNJ | two days later | +3.82% | final price |
| JNJ | three days later | +5.99% | final price |
| JNJ | three days earlier | +2.66% | final price |
| JNJ | five days earlier | +1.93% | final price |
| LLY | that day | +0.62% | final price |
| LLY | the next day | -2.48% | final price |
| LLY | two days later | -3.88% | final price |
| LLY | three days later | +0.21% | final price |
| LLY | three days earlier | +0.54% | final price |
| LLY | five days earlier | -8.42% | final price |
| LNTH | that day | +0.35% | final price |
| LNTH | the next day | -0.08% | final price |
| LNTH | two days later | -0.18% | final price |
| LNTH | three days later | +0.21% | final price |
| LNTH | three days earlier | -0.30% | final price |
| LNTH | five days earlier | -0.68% | final price |
| NEOG | that day | +2.81% | final price |
| NEOG | the next day | -3.55% | final price |
| NEOG | two days later | -2.85% | final price |
| NEOG | three days later | -0.29% | final price |
| NEOG | three days earlier | -2.48% | final price |
| NEOG | five days earlier | +0.08% | final price |
| XLV | that day | +3.08% | final price |
| XLV | the next day | +0.65% | final price |
| XLV | two days later | +0.47% | final price |
| XLV | three days later | +2.39% | final price |
| XLV | three days earlier | +0.48% | final price |
| XLV | five days earlier | -2.31% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a dependent child), worth $15,001 - $50,000 on 11 Sep 2026. That is 54 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Idexx Laboratories (IDXX) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Gilbert Cisneros sold Lantheus Holdings (LNTH), worth $1,001 - $15,000 on 15 Oct 2026. That is 20 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros sold Lantheus Holdings (LNTH), worth $1,001 - $15,000 on 14 Oct 2026. That is 21 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Gilbert Cisneros bought Eli Lilly (LLY), worth $1,001 - $15,000 on 20 Oct 2026. That is 15 days before publication. Filed 10 Nov 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 61 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 28 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 35 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 7 Oct 2026. That is 28 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 51 days before publication. Filed 18 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“IDEXX Laboratories (IDXX) Q3 Earnings Leave Its Premium Valuation In Focus” scores 12 out of 100. The score uses 1 sources.